The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KITE-753: A phase 2 study of an autologous anti-CD19/CD20 CAR T-cell therapy in CAR-naive patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL).
 
Saurabh Dahiya
Consulting or Advisory Role - Adaptive Biotechnologies; Bristol-Myers Squibb; Incyte; Kite, a Gilead Company
Research Funding - Kite, a Gilead Company; Kyverna Therapeutics
 
Timothy Voorhees
Consulting or Advisory Role - ADC Therapeutics; Genmab/AbbVie; Novartis; Recordati
Research Funding - Genmab/AbbVie; Incyte/Morphosys; Kite, a Gilead Company; Recordati; Viracta Therapeutics
Patents, Royalties, Other Intellectual Property - Recordati
 
Matthew Ulrickson
Consulting or Advisory Role - ADC Therapeutics; Autolus; Bristol-Myers Squibb; Stemline Therapeutics
 
Jean Yared
Consulting or Advisory Role - Pierre Fabre
Research Funding - AbbVie; AlloVir; Jazz Pharmaceuticals; Kite, a Gilead Company; Priothera; Regimmune
 
Patrick Reagan
Consulting or Advisory Role - Kite, a Gilead Company
Research Funding - Genentech; Seagen
 
Marie Kersten
Honoraria - Abbvie/Genentech; BMS; Janssen; Kite, a Gilead company; Roche
Consulting or Advisory Role - Adicet BIo; BeiGene (Inst); Janssen (Inst); Kite, a Gilead Company; Miltenyi Biotec (Inst)
Research Funding - Kite, a Gilead company (Inst)
Travel, Accommodations, Expenses - Abbvie; Kite, a Gilead Company
 
Max Topp
Consulting or Advisory Role - AbbVie; AstraZeneca; Autolus; Bristol-Myers Squibb; Incyte; Janssen; Kite, a Gilead Company; Merck
Research Funding - AstraZeneca; Kite, a Gilead Company; Mercl; Regeneron; Roche
Travel, Accommodations, Expenses - BeOne Medicines
 
Lizamarie Bachier
No Relationships to Disclose
 
Michael Jain
Honoraria - Clinical Care Options; OncLive/MJH Life Sciences; Prime Education
Consulting or Advisory Role - Arcellx; Johnson & Johnson/Janssen; Kite/Gilead
Research Funding - Incyte (Inst); Kite/Gilead (Inst); Loxo/Lilly (Inst)
Travel, Accommodations, Expenses - Kite/Gilead
 
Andrew Jallouk
Consulting or Advisory Role - Allogene Therapeutics; Kite/Gilead
Research Funding - Allogene Therapeutics (Inst); Kite/Gilead (Inst)
 
Andre Goy
Employment - OM Pharmaceutical Industries; Regional Cancer Care Associates
Leadership - COTA Healthcare; Genomics Testing Cooperative LLC
Stock and Other Ownership Interests - Alloplex; COTA; Genomics Testing Cooperative LLC; Resilience Care
Consulting or Advisory Role - AbbVie; Clinical Advances in Hematology & Oncology; Janssen; Janssen Biotech; Kite, a Gilead Company; Medscape; Michael J. Hennessey; Novartis; Pharmacyclics
Research Funding - Acerta Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead Company (Inst); MorphoSys (Inst); Pharmacyclics (Inst); Seagen (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Physicians Education Resource, LLC
Other Relationship - Alloplex; AstraZeneca; Bristol-Myers Squibb; Janssen Biotech; Pharmacyclics LLC, an AbbVie Company (steering committee); Vincerx Pharma (advisory board).
 
Ran Reshef
Consulting or Advisory Role - Allogene Therapeutics; Autolus Therapeutics; CareDX; Gilead Sciences; Incyte; Orca Bio; Pierre Fabre; Sail Biomedicines; Sail Biomedicines; Sail Biomedicines; Sana Biotechnology; TScan Therapeutics
Research Funding - Abbvie (Inst); Allogene Therapeutics (Inst); Arcellx (Inst); AstraZeneca (Inst); Atara Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Cabaletta Bio (Inst); CareDX (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); immatics (Inst); Imugene (Inst); Incyte (Inst); Janssen (Inst); Kinomica Limited (Inst); Sanofi (Inst); Sonoma Biotherapeutics (Inst); Synthekine (Inst); Takeda (Inst); TScan Therapeutics (Inst); Vittoria Therapeutics (Inst)
Expert Testimony - Bayer
Travel, Accommodations, Expenses - Gilead Sciences
 
Cameron Turtle
Stock and Other Ownership Interests - Arsenal Biosciences; Cargo Therapeutics; Caribou Biosciences; eGlint; Eureka Therapeutics; Myeloid Therapeutics; Myeloid Therapeutics
Consulting or Advisory Role - AbbVie; Arsenal Biosciences; Boxer Capital; Cargo Therapeutics; Caribou Biosciences; Celgene/Bristol Myers Squibb Cell Therapy; Century Therapeutics; Differentia Bio; eGlint; IQVIA; Merck; Merck Sharp; Myeloid Therapeutics; Nektar; Novartis; Prescient Therapeutics; T-CURX
Research Funding - 10X Genomics; Genscript; Juno Therapeutics/Bristol Myers Squibb; Kite, a Gilead Company/Gilead Sciences; Nektar; Umoja Biopharma
Patents, Royalties, Other Intellectual Property - Fred Hutchinson Cancer Center; Juno/Bristol Myers Squibb
Other Relationship - Kyverna Therapeutics - served as a member of the Data and Safety Monitoring Board (DSMB) )
 
Gary Simmons
Consulting or Advisory Role - McKesson
 
Justyna Kanska
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
Travel, Accommodations, Expenses - Kite, a Gilead Company
 
Jinghui Dong
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
 
Will Watts
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
 
Sara Beygi
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Kite, a Gilead Company
Travel, Accommodations, Expenses - Kite, a Gilead Company
 
Myrna Nahas
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Kite, a Gilead Company
 
Sairah Ahmed
Consulting or Advisory Role - ADC Therapeutics; Bristol-Myers Squibb; Bristol-Myers Squibb; Genmab; Kite, a Gilead Company
Research Funding - Bristol-Myers Squibb; Caribou Biosciences; Genmab; Janssen; Kite, a Gilead Company; Merck; Nektar